SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $822,926 | -50.2% | 1,372,000 | +7.9% | 0.03% | -61.3% |
Q2 2023 | $1,653,600 | -12.4% | 1,272,000 | +18.7% | 0.08% | -29.9% |
Q1 2023 | $1,886,720 | -43.9% | 1,072,000 | 0.0% | 0.11% | -53.9% |
Q4 2022 | $3,366,080 | +29.6% | 1,072,000 | +102.3% | 0.23% | -8.3% |
Q3 2022 | $2,597,000 | +18.4% | 530,000 | 0.0% | 0.25% | +10.0% |
Q2 2022 | $2,194,000 | +11.1% | 530,000 | +55.9% | 0.23% | -9.4% |
Q1 2022 | $1,975,000 | +7.5% | 340,000 | +38.8% | 0.25% | +4.5% |
Q4 2021 | $1,838,000 | – | 245,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |